| Caption | Bing Yao, Ph.D., formerly Senior VP, Head of MedImmune's Respiratory, Inflammation & Autoimmunity Innovative Medicines unit, becomes Chief Executive Officer of Viela Bio |
| Source | 6Dimensions Capital |
| Other pictures |
|
| Download | |
| Related Press Releases Links |
Viela Bio获2.5亿美金A轮融资；通和毓承领投，助力药物创新 Viela Bio Spins Out of MedImmune; Raises Up to $250 Million in Series A Financing, 6 Dimensions Capital Leads Investment |